Transthyretin Familial Amyloid Poluneuropathy Clinical Trial
Official title:
VYNDAQEL DRUG USE INVESTIGATION (REGULATORY POST MARKETING COMMITMENT PLAN)
The purpose of this study is to understand safety (e.g., occurrence of adverse drug reactions [ADRs]) and efficacy data on the long-term use of Vyndaqel Capsules (hereinafter referred to as Vyndaqel) in all patients who received this drug under actual use conditions after its marketing.
Both prospective and retrospective is acceptable All the patients whom an investigator prescribes Vyndaqel should be registered ;